Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro
P Biegański, M Godel, C Riganti, DF Kawano… - Bioorganic …, 2022 - Elsevier
Thanks to development of erlotinib and other target therapy drugs the lung cancer treatment
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …
Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro
P Biegański, M Godel, C Riganti… - Bioorganic …, 2022 - pubmed.ncbi.nlm.nih.gov
Thanks to development of erlotinib and other target therapy drugs the lung cancer treatment
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …
Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro
P Biegański, M Godel, C Riganti, DF Kawano… - Bioorganic …, 2022 - son.uni.lodz.pl
Thanks to development of erlotinib and other target therapy drugs the lung cancer treatment
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …
Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro.
P Biegański, M Godel, C Riganti, DF Kawano… - Bioorganic …, 2021 - europepmc.org
Thanks to development of erlotinib and other target therapy drugs the lung cancer treatment
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …
[引用][C] Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro
P Biegański, K Kowalski, M Godel, C Riganti… - Bioorganic …, 2022 - elibrary.ru
Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro
P Bieganski, M Godel, C Riganti, DF Kawano… - BIOORGANIC …, 2021 - iris.unito.it
Thanks to development of erlotinib and other target therapy drugs the lung cancer treatment
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …
have improved a lot in recent years. However, erlotinib-resistant lung cancer remains an …